Vedolizumab in Crohn Disease genesis-sefh drug evaluation report

Vedolizumab in Crohn Disease genesis-sefh drug evaluation report

Saved in:

Bibliographic Details
Main Authors:	Jenifer González Chávez, Rocio Asensi Diez, Rocío Tamayo Bermejo, Emilio Jesús Alegre del Rey, Noemí Martínez López de Castro
Format:	Article
Language:	English
Published:	Elsevier 2015-09-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/8981.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta
by: Emilio Jesús Alegre del Rey, et al.
Published: (2017-07-01)

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report
by: María Espinosa Bosch, et al.
Published: (2016-07-01)

Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages
by: Juan Carlos del Río-Valencia, et al.
Published: (2018-09-01)

Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report
by: Yolanda Borrego Izquierdo, et al.
Published: (2015-01-01)

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report
by: Patricia Miranda Romero, et al.
Published: (2015-02-01)

Case report: Vedolizumab in Oral Crohn’s disease: the downsides of a gut-specific therapy for a multi-site disease
by: Molly Harte, et al.
Published: (2024-12-01)

Vedolizumab for inflammatory bowel diseasesI
by: Igor L. Khalif, et al.
Published: (2018-08-01)

Farewell open letter to SEFH members
by: José Luis Poveda Andrés
Published: (2015-11-01)

Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies
by: Andrea Pasta, et al.
Published: (2024-11-01)

The Stand of the SEFH Toward a Single Speciality
by: Olga Delgado-Sánchez, et al.
Published: (2020-03-01)

The SEFH National Survey: An Essential Strategic Planning Resource
by: Paul W. Abramowitz, et al.
Published: (2021-01-01)

Data mining and analysis of adverse events of Vedolizumab based on the FAERS database
by: Qinyun Xu, et al.
Published: (2025-01-01)

61th Congress of the SEFH. Top five clinical cases
by: Editor Jefe
Published: (2017-05-01)

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations
by: Raquel Fuentes-Irigoyen, et al.
Published: (2018-03-01)

61 SEFH Congress; Outstanding Clinical Cases (second part)
by: Editor Jefe
Published: (2017-09-01)

Hearing loss associated with paromomycin treatment in a patient with visceral leishmaniasis
by: Rocio Asensi-Diez, et al.
Published: (2017-05-01)

Drug evaluation is also a clinical activity
by: Eduardo López-Briz, et al.
Published: (2021-01-01)

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH)
by: Silvia Valero-García, et al.
Published: (2021-03-01)

Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH
by: Ruth Vera, et al.
Published: (2017-11-01)

Myopenia and body fat distribution in hospitalized ulcerative colitis patients: correlations with clinical characteristics and response to vedolizumab
by: Wei Wei, et al.
Published: (2024-12-01)

Spanish Society of Hospital Pharmacy position paper on biosimilar medicines
by: Noemí Martínez-López de Castro, et al.
Published: (2018-07-01)

Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
by: Srđan Marković, et al.
Published: (2024-12-01)

Predictive Value of Albumin to Fibrinogen Ratio and CALLY Index for Diagnosis of Ulcerative Colitis and Mucosal Healing After Vedolizumab Treatment
by: Su K, et al.
Published: (2025-01-01)

Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: A systematic review and meta-analysis
by: Maha Alghamdi, et al.
Published: (2024-11-01)

2019 SEFH National Survey: service portfolio, care activities, education and research in Spain’s hospital pharmacy departments
by: Montserrat Pérez-Encinas, et al.
Published: (2021-01-01)

Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability
by: Marija Jovanović, et al.
Published: (2024-12-01)

Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
by: Ana Alejandra García Robles, et al.
Published: (2018-03-01)

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain’s hospital pharmacy departments
by: Montserrat Pérez-Encinas, et al.
Published: (2020-11-01)

Superior persistence of ustekinumab compared to anti-TNF in vedolizumab-experienced inflammatory bowel diseases patients: a real-world cohort study
by: Horng-Yih Chiu, et al.
Published: (2024-12-01)

Metodología de la enseñanza de portugués a hablantes de español: un marco y una propuesta de planificación del tratamiento de las competencias lingüísticas
by: Rocío Alonso Rey
Published: (2020-12-01)

Ts’akiel. Vestidos rituales, prácticas de transfiguración y temporalidades superpuestas en la fiesta del k’in tajimol (Chenalhó y Polhó, Chiapas)
by: Rocío Noemí Martínez G.
Published: (2017-12-01)

Ik’aletik « Les hommes noirs »
by: Rocío Noemí Martínez González
Published: (2020-07-01)

Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects
by: Yibing Hu, et al.
Published: (2024-12-01)

“International Centres of Excellence in Hospital Pharmacy”; a SEFH new initiative; the role of the clinical pharmacist in the hospital antibiotic stewardship in Northern Ireland
by: Elena Alba Álvaro-Alonso, et al.
Published: (2016-07-01)

THE GENESIS OF THE PIANO TRIO
by: Marta CÎRLEJAN
Published: (2012-06-01)

Abraham in Galatians and in Genesis
by: S. D. Snyman
Published: (2013-12-01)

Soil genesis and classification /
Published: (2011)

The genesis of eternal values
by: K. M. Dolgov
Published: (2014-04-01)

Genesis of spatial terms
by: Claude Vandeloise
Published: (2017-11-01)

Genesis of artesian waters
by: Pavlo M. Ivashchenko, et al.
Published: (2024-11-01)